SCHEMBL4448787

SCHEMBL4448787

Nc1ccc(NC(=O)C2CCCC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.71
HPGD P15428 1/20 0.66
RAB9A P51151 2/20 0.59
STS P08842 1/20 0.59
LMNA P02545 3/20 0.59
NPSR1 Q6W5P4 2/20 0.59
GAA P10253 2/20 0.58
EPHX1 P07099 1/20 0.58
NAMPT P43490 1/20 0.58
MAPT P10636 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
ALDH1A1 P00352 1/20 0.55
PTPN2 P17706 1/20 0.55
ENPP3 O14638 1/20 0.55
ENPP1 P22413 1/20 0.55
SIRT2 Q8IXJ6 1/20 0.55
GFER P55789 1/20 0.54
HDAC3 O15379 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678484 0.98 PTPN1 (0.74) PTPN1HPGDRAB9ASTSLMNA
SCHEMBL23898941 0.92 NAMPT (0.67) PTPN1HPGDRAB9ALMNANPSR1
SCHEMBL116361 0.92 NAMPT (0.67) PTPN1HPGDRAB9ALMNANPSR1
SCHEMBL23899043 0.92 NAMPT (0.67) PTPN1HPGDRAB9ALMNANPSR1
SCHEMBL28656982 0.88 PTPN1 (0.89) PTPN1HPGDRAB9ASTSLMNA
SCHEMBL125695 0.88 PTPN1 (0.89) PTPN1HPGDRAB9ASTSLMNA
SCHEMBL11936021 0.85 PTPN1 (0.57) PTPN1HPGDRAB9ASTSLMNA
SCHEMBL2717891 0.84 ULK1 (0.60) PTPN1HPGDRAB9ALMNANPSR1
SCHEMBL3093740 0.84 ALDH1A1 (0.55) PTPN1HPGDRAB9ASTSLMNA
SCHEMBL4564743 0.84 ULK1 (0.64) PTPN1HPGDRAB9ASTSLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192733-A1 SUBSTITUTED PHENYL ET458HYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS SOUTHERN RESEARCH INSTITUTE 2023-06-22 US disclosed
US-20230192733-A1 SUBSTITUTED PHENYL ET458HYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS SOUTHERN RESEARCH INSTITUTE 2023-06-22 US disclosed
EP-2134676-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE Addex Pharma SA (CH) 2009-12-23 EP disclosed
WO-2008117175-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2008-10-02 WO disclosed
WO-2007084413-A2 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2007-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192733-A1 SUBSTITUTED PHENYL ET458HYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS SARS1, ACE2, ACE PTPN1 2936/4885HPGD 3870/4885RAB9A 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.